Literature DB >> 15546860

Prion-associated increases in Src-family kinases.

Randal R Nixon1.   

Abstract

The prion diseases result from the generation and propagation of an abnormal conformer of the prion protein. It is unclear how this molecular event disrupts neuronal function and viability. Current evidence argues it is not due to loss of normal prion protein activity or direct toxic effects of the abnormal conformer. Both the normal and abnormal prion proteins are glycosylphosphatidylinositol-linked membrane proteins. Conversion to the abnormal isoform results in the formation and accumulation of prion protein aggregates. Because aggregation of glycosylphosphatidylinositol-linked proteins activates Src-family kinases, the activation status and levels of the Src-family kinases in prion disease were investigated. Elevations of Src-family kinases were found in a cell culture model and two separate animal models of prion disease. The elevations in Src kinases preceded the onset of symptoms and occurred concurrently with the appearance of detergent-insoluble prion protein. In addition, the total level of kinases phosphorylated at tyrosine residues associated with activation was increased. Similar alterations were not present in brain homogenates from presymptomatic animals early in the disease course, prion protein-ablated animals, or end-stage Tg2576 mice overexpressing mutant amyloid precursor protein. Identification of similar elevations in cell culture and animal model systems suggests the elevations are a specific response to the presence of the disease-associated conformer. Abnormal regulation of these signal transduction cascades may be a key element in the cellular pathology of the prion diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546860     DOI: 10.1074/jbc.M410883200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Authors:  Mathéa Pietri; Caroline Dakowski; Samia Hannaoui; Aurélie Alleaume-Butaux; Julia Hernandez-Rapp; Audrey Ragagnin; Sophie Mouillet-Richard; Stéphane Haik; Yannick Bailly; Jean-Michel Peyrin; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  Nat Med       Date:  2013-08-18       Impact factor: 53.440

2.  Cellular prion protein activates Caspase 3 for apoptotic defense mechanism in astrocytes.

Authors:  Caroline M S Marques; Tatiana Pedron; Bruno L Batista; Giselle Cerchiaro
Journal:  Mol Cell Biochem       Date:  2021-02-05       Impact factor: 3.396

3.  Induction of ligand-specific PrP (C) signaling in human neuronal cells.

Authors:  Ryan J Arsenault; Yue Li; Andrew Potter; Philip J Griebel; Anthony Kusalik; Scott Napper
Journal:  Prion       Date:  2012-08-23       Impact factor: 3.931

4.  Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells.

Authors:  Alessandro Didonna; Giuseppe Legname
Journal:  Mol Neurodegener       Date:  2010-08-09       Impact factor: 14.195

5.  Novel liposomal formulation for targeted gene delivery.

Authors:  Véronique Rivest; Alix Phivilay; Carl Julien; Sandra Bélanger; Cyntia Tremblay; Vincent Emond; Frédéric Calon
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.580

6.  Common themes in PrP signaling: the Src remains the same.

Authors:  Katharina Ochs; Edward Málaga-Trillo
Journal:  Front Cell Dev Biol       Date:  2014-10-28

7.  Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo.

Authors:  Emily Sempou; Emiliano Biasini; Alejandro Pinzón-Olejua; David A Harris; Edward Málaga-Trillo
Journal:  Mol Neurodegener       Date:  2016-02-09       Impact factor: 14.195

8.  Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance.

Authors:  E Pradines; J Hernandez-Rapp; A Villa-Diaz; C Dakowski; H Ardila-Osorio; S Haik; B Schneider; J-M Launay; O Kellermann; J-M Torres; S Mouillet-Richard
Journal:  Cell Death Dis       Date:  2013-01-10       Impact factor: 8.469

9.  Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs.

Authors:  Alexander Rouvinski; Sharon Karniely; Maria Kounin; Sanaa Moussa; Miri D Goldberg; Gabriela Warburg; Roman Lyakhovetsky; Dulce Papy-Garcia; Janine Kutzsche; Carsten Korth; George A Carlson; Susan F Godsave; Peter J Peters; Katarina Luhr; Krister Kristensson; Albert Taraboulos
Journal:  J Cell Biol       Date:  2014-02-03       Impact factor: 10.539

10.  Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP.

Authors:  Rory H Shott; Cathy Appanah; Catherine Grenier; Guillaume Tremblay; Xavier Roucou; Luis M Schang
Journal:  Virol J       Date:  2014-10-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.